$NA
Nano Labs Ltd Stock $na

$na Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024031192 Filed on April 08, 2024

Income Statement

Concept	2023	2022 Q4
Revenue	78.34M cnies	$12.74M
YoY Change	-92.03%
Cost Of Revenue	$25.67M	$89.29M
YoY Change	-96.59%
Gross Profit	-$14.61M	-$76.55M
YoY Change	-106.35%
Gross Profit Margin	-18.65%	-600.9%
Selling, General & Admin	$9.705M	$21.11M
YoY Change	-87.5%
% of Gross Profit
Research & Development	$12.51M	$39.21M
YoY Change	-90.51%
% of Gross Profit
Depreciation & Amortization	$624.4K
YoY Change	10.71%
% of Gross Profit
Operating Expenses	$22.21M	$60.32M
YoY Change	-89.4%
Operating Profit	-$36.82M	-$136.9M
YoY Change	-278.01%
Interest Expense	-$431.0K	$1.389M
YoY Change	-106.72%
% of Operating Profit
Other Income/Expense, Net	$905.8K	$2.691M
YoY Change	-77.48%
Pretax Income	-$35.91M	-$132.8M
YoY Change	-215.41%
Income Tax	-17.39K cnies	$0.00
% Of Pretax Income
Net Earnings	-252.8M cnies	-$132.8M
YoY Change	-912.44%
Net Earnings / Revenue	-322.75%	-1042.34%
Basic Earnings Per Share	-$0.61
Diluted Earnings Per Share	-$0.61	-$1.19
COMMON SHARES
Basic Shares Outstanding	58.89M shares
Diluted Shares Outstanding	58.89M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.17M	$48.17M	$87.81M
YoY Change	-45.15%	-45.15%
Cash & Equivalents	$6.800M	$48.17M	$87.81M
Short-Term Investments			$0.00
Other Short-Term Assets	37.91M cnies	$28.67M	$98.64M
YoY Change	-61.57%	-70.93%	137.91%
Inventory	12.87M cnies	$12.88M	$102.2M
Prepaid Expenses	24.39M cnies		$71.31M
Receivables	$245.5K	$1.739M
Other Receivables	$0.00	$34.04M
Total Short-Term Assets	$17.72M	$125.5M	$288.7M
YoY Change	-93.86%	-56.52%	-67.69%
LONG-TERM ASSETS
Property, Plant & Equipment	169.7M cnies	$177.1M	$29.87M
YoY Change	467.88%	492.73%	312.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$31.74M	$224.8M	$78.59M
YoY Change	-59.61%	186.05%	379.08%
TOTAL ASSETS
Total Short-Term Assets	$17.72M	$125.5M	$288.7M
Total Long-Term Assets	$31.74M	$224.8M	$78.59M
Total Assets	$49.46M	$350.3M	$367.2M
YoY Change	-86.53%	-4.61%	-59.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.383M	$16.88M	$15.29M
YoY Change	-84.42%	10.35%	438.93%
Accrued Expenses	$3.480M	$10.49M	$4.199M
YoY Change	-17.13%	149.87%
Deferred Revenue	107.8M cnies		$124.5M
YoY Change	-13.37%		-86.43%
Short-Term Debt	$2.824M	$20.00M	$0.00
YoY Change
Long-Term Debt Due	$481.5K	$3.410M	$280.0K
YoY Change	71.95%	1117.86%
Total Short-Term Liabilities	$34.25M	$242.6M	$183.6M
YoY Change	-81.35%	32.09%	-80.3%
LONG-TERM LIABILITIES
Long-Term Debt	$16.98M	$120.3M	$16.67M
YoY Change	1.84%	621.28%
Other Long-Term Liabilities	$3.731M	$3.731M	$2.514M
YoY Change	48.4%	48.4%
Total Long-Term Liabilities	$16.98M	$124.0M	$19.19M
YoY Change	-11.51%	546.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.25M	$242.6M	$183.6M
Total Long-Term Liabilities	$16.98M	$124.0M	$19.19M
Total Liabilities	$51.75M	$365.0M	$202.8M
YoY Change	-74.48%	79.97%	-78.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.82M		-$28.60M
YoY Change	123.13%		-87.21%
Common Stock	$60.47M		354.8M cnies
YoY Change	-82.96%		529694.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.080M	-$14.73M	$164.4M
YoY Change
Total Liabilities & Shareholders Equity	$49.46M	$350.3M	$367.2M
YoY Change	-86.53%	-4.61%	-59.64%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income		-252.8M cnies	-$132.8M
YoY Change		-912.44%
Depreciation, Depletion And Amortization		$624.4K
YoY Change		10.71%
Cash From Operating Activities		-$18.85M
YoY Change		-52.26%
INVESTING ACTIVITIES
Capital Expenditures		$14.89M
YoY Change		491.65%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$14.89M
YoY Change		212.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$5.190M	$10.28M
YoY Change
Debt Paid & Issued, Net		$216.0K
YoY Change		974.61%
Cash From Financing Activities		$28.17M
YoY Change		21.86%
NET CHANGE
Cash From Operating Activities		-$18.85M
Cash From Investing Activities		-$14.89M
Cash From Financing Activities		$28.17M
Net Change In Cash		-$5.545M
YoY Change		-73.55%
FREE CASH FLOW
Cash From Operating Activities		-$18.85M
Capital Expenditures		$14.89M
Free Cash Flow		-$33.74M
YoY Change		-19.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41426
CY2023	dei	Entity Registrant Name EntityRegistrantName	Nano Labs Ltd
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	China Yuangu Hanggang Technology Building 509 Qianjiang Road,
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Shangcheng District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Hangzhou, Zhejiang
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	310000
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Security12b Title Security12bTitle	Class A ordinary shares
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87811272	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48164664	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6800325	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	48112	cny
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	417990	cny
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	59016	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1739065	cny
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	245537	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	102201746	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	12874986	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	1817808	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	71314254	cny
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24386010	cny
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3443039	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	27275215	cny
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	37908092	cny
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5352209	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	288650599	cny
CY2023Q4	us-gaap	Assets Current AssetsCurrent	125490807	cny
CY2023Q4	us-gaap	Assets Current AssetsCurrent	17717934	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21426955	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169653582	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23953236	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48717132	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47731288	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6739137	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8447978	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7424554	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1048266	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	78592065	cny
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	224809424	cny
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	31740639	usd
CY2022Q4	us-gaap	Assets Assets	367242664	cny
CY2023Q4	us-gaap	Assets Assets	350300231	cny
CY2023Q4	us-gaap	Assets Assets	49458573	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	20000000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2823782	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	280000	cny
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3410000	cny
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	481455	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15292843	cny
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16875586	cny
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2382649	usd
CY2022Q4	us-gaap	Advance Rent AdvanceRent	124469097	cny
CY2023Q4	us-gaap	Advance Rent AdvanceRent	107826617	cny
CY2023Q4	us-gaap	Advance Rent AdvanceRent	15223942	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4199361	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3479752	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	491303	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39399532	cny
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	90978171	cny
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12845126	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	183640833	cny
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	242570126	cny
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	34248257	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	16673316	cny
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	120260783	cny
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	16979511	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2514115	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3730672	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	526730	usd
CY2022Q4	us-gaap	Liabilities Liabilities	202828264	cny
CY2023Q4	us-gaap	Liabilities Liabilities	366561581	cny
CY2023Q4	us-gaap	Liabilities Liabilities	51754498	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	354803564	cny
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	428310028	cny
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	60472706	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199207921	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-452031693	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63821945	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Retained Earnings Not Available For Dividends StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends	6647109	cny
CY2023Q4	us-gaap	Statutory Accounting Practices Retained Earnings Not Available For Dividends StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends	6647109	cny
CY2023Q4	us-gaap	Statutory Accounting Practices Retained Earnings Not Available For Dividends StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends	938499	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2099329	cny
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2254558	cny
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	318319	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	164414400	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-14732998	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2080138	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1528352	cny
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-215787	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164414400	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16261350	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2295925	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	367242664	cny
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	350300231	cny
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49458573	usd
CY2021	us-gaap	Revenues Revenues	39440897	cny
CY2022	us-gaap	Revenues Revenues	983168898	cny
CY2023	us-gaap	Revenues Revenues	78335376	cny
CY2023	us-gaap	Revenues Revenues	11060101	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	43530708	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	753004179	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	181784576	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	25666000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-4089811	cny
CY2022	us-gaap	Gross Profit GrossProfit	230164719	cny
CY2023	us-gaap	Gross Profit GrossProfit	-103449200	cny
CY2023	us-gaap	Gross Profit GrossProfit	-14605899	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5119072	cny
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24431649	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15332523	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2164785	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24121823	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53197248	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53402101	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7539794	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	145455181	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131851602	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	88601470	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12509561	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	174696076	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	209480499	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	157336094	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	22214140	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-178785887	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	20684220	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-260785294	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-36820039	usd
CY2021	ck0001872302	Finance Income Expense FinanceIncomeExpense	-509764	cny
CY2022	ck0001872302	Finance Income Expense FinanceIncomeExpense	4407504	cny
CY2023	ck0001872302	Finance Income Expense FinanceIncomeExpense	-920055	cny
CY2023	ck0001872302	Finance Income Expense FinanceIncomeExpense	-129902	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	3495208	cny
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2005580	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	489098	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	69055	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	855959	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4021582	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6846803	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	966694	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3841403	cny
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10434666	cny
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6415846	cny
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	905847	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-174944484	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31118886	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-254369448	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35914192	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17394	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2456	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-174944484	cny
CY2022	us-gaap	Profit Loss ProfitLoss	31118886	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-254352054	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-35911736	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1528282	cny
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-215777	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-174944484	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	31118886	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-252823772	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-35695959	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-174944484	cny
CY2022	us-gaap	Profit Loss ProfitLoss	31118886	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-254352054	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-35911736	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2467327	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4566656	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-155159	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-21907	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-177411811	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	35685542	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-254196895	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-35889829	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1528352	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-215787	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-177411811	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35685542	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-252668543	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35674042	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.89
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	26753768	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	184073191	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	60767978	cny
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.29
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.89
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44938990	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53244500	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58885071	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58885071	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44938990	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53307605	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58885071	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58885071	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-48520332	cny
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	201199989	cny
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	51135	cny
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	19344	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-174944484	cny
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2467327	cny
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-24661675	cny
CY2022	ck0001872302	Stock Issued During Period Value Share Issuance Initial Public Offering Net Of Issuance Cost StockIssuedDuringPeriodValueShareIssuanceInitialPublicOfferingNetOfIssuanceCost	111939400	cny
CY2022	ck0001872302	Stock Issued During Period Value Share Issuance Following Initial Public Offering Net Of Issuance Cost StockIssuedDuringPeriodValueShareIssuanceFollowingInitialPublicOfferingNetOfIssuanceCost	32103786	cny
CY2022	us-gaap	Profit Loss ProfitLoss	31118886	cny
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	9347347	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4566656	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164414400	cny
CY2023	ck0001872302	Stock Issued During Period Value Issuance Of Ordinary Shares StockIssuedDuringPeriodValueIssuanceOfOrdinaryShares	72802000	cny
CY2023	ck0001872302	Stock Issued During Period Value Issuance Of Ordinary Shares Upon The Exercise Of Stock Options StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesUponTheExerciseOfStockOptions	734	cny
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	718411	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-254352054	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	155159	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16261350	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2295925	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-174944484	cny
CY2022	us-gaap	Profit Loss ProfitLoss	31118886	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-254352054	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-35911736	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2920433	cny
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5505422	cny
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5752591	cny
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	812203	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2609699	cny
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3928131	cny
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4422560	cny
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	624417	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	12088	cny
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-113588	cny
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-16037	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	19344	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	9347347	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	718411	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	101432	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	8579776	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1165716	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1732378	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	244593	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	233385726	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	71446484	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-28782243	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4063739	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	364369453	cny
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-304300103	cny
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-47159593	cny
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-6658420	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	38564595	cny
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-51740635	cny
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-511358	cny
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-72198	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1937951	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10591202	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	898564	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	126867	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-4716981	cny
CY2021	ck0001872302	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	851987235	cny
CY2022	ck0001872302	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	-794302470	cny
CY2023	ck0001872302	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	-16662392	cny
CY2023	ck0001872302	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	-2352548	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4687184	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5330448	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4349974	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-614169	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	5019233	cny
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4466304	cny
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5504025	cny
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-777108	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71732868	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-274940789	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-133473937	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18845065	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8692683	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17531162	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105482822	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14893024	usd
CY2021	ck0001872302	Refund Of Prepayment For Property And Equipment RefundOfPrepaymentForPropertyAndEquipment	550000	cny
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	32293440	cny
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	33640500	cny
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	49292208	cny
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	cny
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4490000	cny
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36046123	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33182870	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105482822	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14893024	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	31355000	cny
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	201199989	cny
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	144043186	cny
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72802734	cny
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10278952	usd
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	51135	cny
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	17093316	cny
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	128247467	cny
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	18107144	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	140000	cny
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1530000	cny
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	216019	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	5000000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	164896124	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	160996502	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	199520201	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28170077	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2062387	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1132887	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	159828	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22566	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	198520482	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-145994270	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39276730	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5545446	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35333172	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233853654	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87859384	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12404787	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233853654	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87859384	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48582654	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6859341	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	180619	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3773028	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	532710	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	276186	cny
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	89169	cny
CY2022	ck0001872302	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modificationin Dollars RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationinDollars	4557092	cny
CY2023	ck0001872302	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modificationin Dollars RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationinDollars	5015808	cny
CY2023	ck0001872302	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modificationin Dollars RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationinDollars	708177	usd
CY2023	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	46180063	cny
CY2023	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	6520121	usd
CY2023	ck0001872302	Working Capital Deficit WorkingCapitalDeficit	117000000	cny
CY2023	ck0001872302	Financial Statements Term FinancialStatementsTerm	P1Y
CY2023Q4	us-gaap	Cash Cash	48164664	cny
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Significant accounting estimates reflected in the Company’s consolidated financial statements including, but not limited to, inventory write-down, impairment of long-lived assets, valuation allowance for deferred tax assets and share-based compensation.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b><i>Concentration of credit risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents with financial institutions with high credit ratings and quality.</p>
CY2022Q4	us-gaap	Cash Cash	87811272	cny
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	48112	cny
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	417990	cny
CY2021	us-gaap	Revenues Revenues	39440897	cny
CY2022	us-gaap	Revenues Revenues	983168898	cny
CY2023	us-gaap	Revenues Revenues	78335376	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	124469097	cny
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	107826617	cny
CY2021	ck0001872302	Contract Liabilities As Revenue ContractLiabilitiesAsRevenue	4241270	cny
CY2022	ck0001872302	Contract Liabilities As Revenue ContractLiabilitiesAsRevenue	804875532	cny
CY2023	ck0001872302	Contract Liabilities As Revenue ContractLiabilitiesAsRevenue	23740945	cny
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	992996	cny
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	10901200	cny
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1278586	cny
CY2021	ck0001872302	Shipping And Handling Costs ShippingAndHandlingCosts	371769	cny
CY2022	ck0001872302	Shipping And Handling Costs ShippingAndHandlingCosts	4233084	cny
CY2023	ck0001872302	Shipping And Handling Costs ShippingAndHandlingCosts	2122358	cny
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	37908092	cny
CY2021	us-gaap	Revenues Revenues	39440897	cny
CY2022	us-gaap	Revenues Revenues	983168898	cny
CY2023	us-gaap	Revenues Revenues	78335376	cny
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	23731587	cny
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	34041675	cny
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	69914306	cny
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	56952428	cny
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	158693203	cny
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	130609171	cny
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	81807783	cny
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	90377688	cny
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	208213546	cny
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	265064301	cny
CY2022Q4	us-gaap	Inventory Net InventoryNet	102201746	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	12874986	cny
CY2022Q4	ck0001872302	Prepayments Inventories And Processing Fee PrepaymentsInventoriesAndProcessingFee	64813532	cny
CY2023Q4	ck0001872302	Prepayments Inventories And Processing Fee PrepaymentsInventoriesAndProcessingFee	14645763	cny
CY2022Q4	ck0001872302	Prepayments Design Fees PrepaymentsDesignFees	3850329	cny
CY2023Q4	ck0001872302	Prepayments Design Fees PrepaymentsDesignFees	7162700	cny
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2650393	cny
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2577547	cny
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	71314254	cny
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24386010	cny
CY2022Q4	us-gaap	Deposit Assets DepositAssets	3434080	cny
CY2023Q4	us-gaap	Deposit Assets DepositAssets	2361968	cny
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	109548	cny
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1504449	cny
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	27275215	cny
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9537316	cny
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12098631	cny
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	266252	cny
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	266252	cny
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1550648	cny
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1550648	cny
CY2022Q4	ck0001872302	Transportation Equipment TransportationEquipment	41014	cny
CY2023Q4	ck0001872302	Transportation Equipment TransportationEquipment	41014	cny
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	16119419	cny
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	165221605	cny
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6087694	cny
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9524568	cny
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21426955	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169653582	cny
CY2021	us-gaap	Depreciation Depreciation	2510398	cny
CY2022	us-gaap	Depreciation Depreciation	3353055	cny
CY2023	us-gaap	Depreciation Depreciation	3436716	cny
CY2022Q4	us-gaap	Land Improvements LandImprovements	49292208	cny
CY2023Q4	us-gaap	Land Improvements LandImprovements	49292208	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	334865	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	334865	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	909941	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1895785	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48717132	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47731288	cny
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99301	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	575076	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	985844	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48717132	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47731288	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	985844	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	985844	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	985844	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	985844	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	985844	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	42802068	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47731288	cny
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	3277780	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	11385312	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6051298	cny
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1867850	cny
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	295564	cny
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	198306	cny
CY2021	us-gaap	Lease Cost LeaseCost	5145630	cny
CY2022	us-gaap	Lease Cost LeaseCost	11680876	cny
CY2023	us-gaap	Lease Cost LeaseCost	6249604	cny
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	5068864	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5822406	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	4648690	cny
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M10D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0624	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0624	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3605781	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1194360	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1194360	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1197632	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	602088	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7794221	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	583797	cny
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7210424	cny
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8536985	cny
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7013473	cny
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	10000000	cny
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	10000000	cny
CY2023Q4	ck0001872302	Accrued Construction In Progress AccruedConstructionInProgress	46180063	cny
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	13609170	cny
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	13604797	cny
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7253377	cny
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14179838	cny
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39399532	cny
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	90978171	cny
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	20000000	cny
CY2023Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	148000000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3410000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4630000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5850000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7070000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8290000	cny
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	94420783	cny
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	123670783	cny
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	81000000	cny
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12600000	usd
CY2021Q3	us-gaap	Shares Issued SharesIssued	1895000	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18950000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122300000	cny
CY2023Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	10000000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	72802000	cny
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5189500	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	504557	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0002
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	273155	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	5353523	shares
CY2023	ck0001872302	Recipient Employees And Directors Upon Vesting RecipientEmployeesAndDirectorsUponVesting	895018	shares
CY2023Q4	ck0001872302	Share Based Compensation Arrangement By Share Based Payment Award Unassigned Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardUnassignedShares	214149	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.8
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3701	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0151	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	ck0001872302	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0	pure
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9329484	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	712184	cny
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.10	pure
CY2023	ck0001872302	Percentage Of Reserve Capital PercentageOfReserveCapital	0.50	pure
CY2022	ck0001872302	Statutory Reserve StatutoryReserve	6647109	cny
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	312386	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-174944484	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	31118886	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-252823772	cny
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44938990	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53244500	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58885071	shares
CY2021	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	-3.89
CY2022	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	0.58
CY2023	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	-4.29
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-174944484	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	31118886	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-252823772	cny
CY2021	ck0001872302	Weighted Average Number Diluted Shares Outstanding Before Adjustment WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment	44938990	shares
CY2022	ck0001872302	Weighted Average Number Diluted Shares Outstanding Before Adjustment WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment	53244500	shares
CY2023	ck0001872302	Weighted Average Number Diluted Shares Outstanding Before Adjustment WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment	58885071	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	63105	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44938990	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53307605	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58885071	shares
CY2021	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-3.89
CY2022	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	0.58
CY2023	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-4.29
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-17394	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17394	cny
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	63038127	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	77373944	usd
CY2022Q4	ck0001872302	Accrued Expense And Others AccruedExpenseAndOthers	-29335373	usd
CY2023Q4	ck0001872302	Accrued Expense And Others AccruedExpenseAndOthers	-282843	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	47198866	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	51027391	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	80901620	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	128118492	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	80901620	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	128118492	usd
CY2021	ck0001872302	Deferred Tax Assets Provision For Valuation Allowance DeferredTaxAssetsProvisionForValuationAllowance	42631572	cny
CY2022	ck0001872302	Deferred Tax Assets Provision For Valuation Allowance DeferredTaxAssetsProvisionForValuationAllowance	24519326	cny
CY2023	ck0001872302	Deferred Tax Assets Provision For Valuation Allowance DeferredTaxAssetsProvisionForValuationAllowance	47333923	cny
CY2022	ck0001872302	Reversal Of Valuation Allowance ReversalOfValuationAllowance	6100147	cny
CY2023	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchase for the years ended December 31, 2021, 2022 and 2023:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="10" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Years Ended December 31,</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Supplier A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">38</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">—</div></td><td style="text-align: left"> </td></tr> </table>
CY2023	ck0001872302	Construction In Progress Amount ConstructionInProgressAmount	39119300	cny
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	47000000	cny
CY2023Q4	ck0001872302	Frozen Amount FrozenAmount	418201	cny
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		cny
CY2022Q4	us-gaap	Minority Interest MinorityInterest		cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		cny
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		cny
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		cny
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		cny
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2022	ck0001872302	Refund Of Prepayment For Property And Equipment RefundOfPrepaymentForPropertyAndEquipment		cny
CY2023	ck0001872302	Refund Of Prepayment For Property And Equipment RefundOfPrepaymentForPropertyAndEquipment		cny
CY2023	ck0001872302	Refund Of Prepayment For Property And Equipment RefundOfPrepaymentForPropertyAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		cny
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		cny
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		cny
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		cny
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		cny
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		cny
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		cny
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		cny
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		cny
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		cny
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		cny
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		cny
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	ck0001872302	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modificationin Dollars RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationinDollars		cny
CY2021	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice		cny
CY2022	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice		cny
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022Q4	ck0001872302	Accrued Construction In Progress AccruedConstructionInProgress		cny
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		cny
CY2021	ck0001872302	Statutory Reserve StatutoryReserve		usd
CY2023	ck0001872302	Statutory Reserve StatutoryReserve		usd
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		cny
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		cny
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	ck0001872302	Reversal Of Valuation Allowance ReversalOfValuationAllowance		cny
CY2021	ck0001872302	Reversal Of Valuation Allowance ReversalOfValuationAllowance		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001872302

Files In Submission

Name	View Source	Status
0001213900-24-031192-index-headers.html	Edgar Link	pending
0001213900-24-031192-index.html	Edgar Link	pending
0001213900-24-031192.txt	Edgar Link	pending
0001213900-24-031192-xbrl.zip	Edgar Link	pending
ck0001872302-20231231.xsd	Edgar Link	pending
ea0202375-20f_nanolabs.htm	Edgar Link	pending
ea020237501ex1-1_nanolabs.htm	Edgar Link	pending
ea020237501ex12-1_nanolabs.htm	Edgar Link	pending
ea020237501ex12-2_nanolabs.htm	Edgar Link	pending
ea020237501ex13-1_nanolabs.htm	Edgar Link	pending
ea020237501ex13-2_nanolabs.htm	Edgar Link	pending
ea020237501ex15-1_nanolabs.htm	Edgar Link	pending
ea020237501ex15-2_nanolabs.htm	Edgar Link	pending
ea020237501ex2-2_nanolabs.htm	Edgar Link	pending
ea020237501ex8-1_nanolabs.htm	Edgar Link	pending
ea020237501ex97-1_nanolabs.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
ck0001872302-20231231_def.xml	Edgar Link	unprocessable
ck0001872302-20231231_lab.xml	Edgar Link	unprocessable
ck0001872302-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0202375-20f_nanolabs_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ck0001872302-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NA
Nano Labs Ltd Stock $na

2023 Q4 Form 20-F Financial Statement

#000121390024031192 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NA Nano Labs Ltd Stock $na

2023 Q4 Form 20-F Financial Statement

#000121390024031192 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NA
Nano Labs Ltd Stock $na